Extracorporeal life support in cardiogenic shock: exploring before liberalizing


  • Tiago R. Velho Cardiothoracic Surgery Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, EPE, Lisbon, Portugal; Cardiothoracic Surgery Research Unit, Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal; Innate Immunity and Inflammation Laboratory, Instituto Gulbenkian de Ciência, Oeiras, Portugal https://orcid.org/0000-0002-0455-8189




Download data is not yet available.


H. Thiele, E. M. Ohman, S. De Waha-Thiele, U. Zeymer, and S. Desch, “Management of cardiogenic shock complicating myocardial infarction: an update 2019,” Eur. Heart J., vol. 40, no. 32, pp. 2671–2683, Aug. 2019, doi: 10.1093/eurheartj/ ehz363.

B. Redfors et al., “17-year trends in incidence and prognosis of cardiogenic shock in patients with acute myocardial infarction in western Sweden,” Int. J. Cardiol., vol. 185, pp. 256–262, Apr. 2015, doi: 10.1016/j.ijcard.2015.03.106.

S. A. Wayangankar et al., “Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction,” JACC Cardiovasc. Interv., vol. 9, no. 4, pp. 341–351, Feb. 2016, doi: 10.1016/j.jcin.2015.10.039.

H. Thiele et al., “Extracorporeal Life Support in Infarct-Related Cardiogenic Shock,” N. Engl. J. Med., vol. 389, no. 14, pp. 1286–1297, Oct. 2023, doi: 10.1056/NEJMoa2307227.

P. Ostadal et al., “Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial,” Circulation, vol. 147, no. 6, pp. 454–464, Feb. 2023, doi: 10.1161/CIRCULATIONAHA.122.062949.




How to Cite

Velho TR. Extracorporeal life support in cardiogenic shock: exploring before liberalizing. Rev Port Cir Cardiotorac Vasc [Internet]. 2024 Feb. 9 [cited 2024 Feb. 28];30(4):11-2. Available from: https://pjctvs.com/index.php/journal/article/view/426